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pathological impact. These include well-established
sleep-state-speciﬁc or circadian-controlled changes inIntroduction
endocrine release, convulsive thresholds, regulation of
Sleep-disorders medicine has emerged as a genuine clini- breathing, cardiovascular control, gastrointestinal phys-
cal ﬁeld, yet few studies have examined sleep disorders iology, and muscle tone.
from the human-genetic perspective. Sleep itself is a vital Clinically, the most frequent sleep disorders are in-
behavior of unknown function that consumes one-third somnia (whether or not of chronobiological origin), ob-
of any given human life; animals die if totally deprived structive sleep apnea, restless-leg syndrome/periodic leg
of sleep (Rechtschaffen et al. 1983; Kushida et al. 1989). movements, and narcolepsy. In this review, I will brieﬂy
A genetic approach in sleep-disorders research thus not demonstrate the involvement of genetic factors in the
only might have therapeutic applications but also could regulation of normal and abnormal sleep and will review
indirectly help our understanding of this important the potential of the ﬁeld of genetics in the study of sleep
physiological behavior. disorders.
The complexity of sleep as a physiological phenome-
non is matched by an increasing number of pathologies Genetic Control of Normal Human Sleep:
(ú50; see Thorpy 1994) now catalogued by interna- Twin Studies
tional classiﬁcations. Electrophysiological studies have
Research in this area is primarily based on question-long shown that sleep is a heterogeneous state, most
naire studies comparing sleep habits (duration of sleep,classically separated into rapid-eye movement (REM)
schedules and quality of night sleep, and frequency ofand non-REM sleep. In humans, non-REM sleep can
napping) in MZ and DZ twin pairs (Gedda and Brencialso be subdivided into light non-REM sleep (stage I
1983; Partinen et al. 1983; Heath et al. 1990; Drennanand stage II) and slow-wave sleep (SWS; stage III and
et al. 1992). For most of the variables analyzed, correla-stage IV). Independent of this organization by sleep
tions are higher for MZ twins than for DZ twins. Thisstage, the propensity to sleep or to stay awake is regu-
effect remains signiﬁcant even when twins do not sharelated independently by homeostatic (sleep-debt depen-
the same environment (Partinen et al. 1983) and doesdent) and circadian (clock dependent) processes. The
not correlate strongly with depression or anxiety (Ken-importance of circadian factors can be best illustrated
dler et al. 1987). Environmental factors, however, doin the absence of time cues. In these conditions, sleep,
contribute signiﬁcantly to the variance (Partinen et al.wakefulness, core temperature, and various other behav-
1983; Heath et al. 1990). Measures of the residual vari-iors still ﬂuctuate with a periodicity close to 24 h, called
ance between MZ twins (1 0 rmz) quantify the inﬂuencethe ‘‘free-running circadian period’’ (t). Circadian and
of environmental factors speciﬁc to each twin pair (Hru-homeostatic factors have distinct anatomical substrates,
bec and Robinette 1984). In all studies, correlationscircadian factors regulating sleep and wakefulness being
barely reach .60, thus suggesting that half of the variancemostly if not exclusively localized in the hypothalamus,
is associated with environmental factors. Since twins livewithin the suprachiasmatic nuclei. Finally, sleep is asso-
in similar environments, this difference probably corre-ciated with a host of physiological changes that have a
sponds to short-term environmental variance.
Several authors have studied sleep in MZ and DZ
twins, using polygraphic techniques (Webb and Camp-
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more particularly alpha-occipital rhythms during awake DBA and BALB/c but not C57BR display high-ampli-
tude spindles, whereas REM-associated theta frequencyresting electroencephalogram (EEG), suggested domi-
nant transmission for this trait, thus showing that EEG varies signiﬁcantly between strains (Valatx and Buget
1974; Valatx 1984).genetic variations are not only quantitative but also
qualitative (Vogel 1986; Anokhin et al. 1992); a linkage These phenotypic differences are genetically trans-
mitted. Diallelic methods (Friedmann 1974), simplemarker for low-voltage alpha EEG has now been identi-
ﬁed on human chromosome 20q (Anokhin et al. 1992; segregation analysis in a backcross setting (Valatx and
Buget 1974), and recombinant inbred-strain studiesSteinlein et al. 1992). More recently, Van Beijsterveldt
et al. (1996), studying awake resting EEG frequencies (Schwartz and Zimmerman 1990; Hofstetter et al.
1995) suggest that many genes are involved in the ex-in a large number of MZ and DZ twins, could also
demonstrate high average heritabilities (.76–.89) for all pression of each trait (Valatx et al. 1972; Friedmann
1974; Rosenberg et al. 1987; Schwartz and Zimmer-analyzed EEG frequency bands.
Most of the early studies did not take into account man 1990; Hofstetter et al. 1995). The interactions
observed are complex and not strictly additive, withthe fact that sleep is independently regulated by circa-
dian and homeostatic factors. Linkowski et al. (1992, hybrids of inbred strains occasionally presenting im-
portant deviations when compared with the average in1993) tried to address this issue by measuring cortisol
and prolactin levels in twins. Results suggest that genetic parental strains (Friedmann 1974).
factors play a major role in the regulation of cortisol
secretion but not in that of prolactin secretion. Drennan Pharmacogenetic Approaches in Rodents
et al. (1992) used the Horne-Ostberg questionnaire to
examine morningness/eveningness in 238 twin pairs and The basis of this technique is the selection of animal
strains relatively sensitive or resistant to pharmacologi-found higher correlations in MZ pairs, thus suggesting
the existence of human circadian genetic factors. Such cal agents, for example, ethanol (McClearn and Kaki-
hana 1973; Morzorati et al. 1988; Phillips et al. 1989),studies certainly could be extended. As of today, there
has been no twin study measuring SWS/REM sleep ho- benzodiazepines (Korpi et al. 1993), barbiturates (Stino
1992), or cholinergic compounds (Overstreet et al.meostasis or circadian-rhythm properties under optimal
experimental conditions. 1990; Shiromani et al. 1991). These models can then be
studied pharmacologically, physiologically, and geneti-
cally. Mice that have been selected for their hypersensi-Genetic Inﬂuences on Animal Sleep
tivity to cholinergic compounds display, for example,
an increase in paradoxical sleep (Shiromani et al. 1991),Animal studies also support the concept of genetic
inﬂuences on sleep. Major differences in overall sleep which conﬁrms the role of acetylcholine in REM-sleep
regulation.amount and distribution or in SWS versus REM sleep
as percentage of total sleep time can be observed within The Long-Sleep (LS) and Short-Sleep (SS) mouse
strains have been the most intensively studied (Phillipsthe same species, these differences being resistant to pro-
longed manipulations such as forced immobilization or et al. 1989; Markel et al. 1996). These mouse strains
were created in the 1970s by selecting mice more or lesssleep-deprivation amount (Webb and Friedmann 1971;
Kitahama and Valatx 1980; Valatx 1984; Rosenberg et sensitive to the sedative effects of ehtanol, measured as
the duration of loss of the righting reﬂex (‘‘sleep time’’)al. 1987). Signiﬁcant variations in sleep/wake architec-
ture and EEG proﬁles are also observed between rodent after administration of ethanol (McLearn and Kaki-
hana 1973). After 18 generations of selection, the re-inbred strains (Valatx et al. 1972; Friedmann 1974; Van
Twyver et al. 1973; Valatx and Buget 1974; Kitahama sulting strains now present an average ‘‘sleep’’ time of
10 min (SS) or 2 h (LS) after ingestion of a similar doseand Valatx 1980; Valatx 1984; Rosenberg et al. 1987;
Benca et al. 1991; Leung et al. 1992). C57BL or C57BR of ethanol. These animals have been particularly useful
in two research areas. First, it is well established thatstrains are characterized by long REM-sleep episodes,
short SWS episodes, and signiﬁcant circadian variation there is pharmacological overlap between anesthetics,
ethanol, and most benzodiazepine and barbituric hyp-under light:dark conditions (Valatx and Buget 1974;
Valatx 1984). At the opposite end of the spectrum, notics. Partial or total cross-tolerance is observed for
numerous pharmacological properties (Khanna et al.BALB/c is characterized by REM-sleep episodes of very
short duration and weak circadian ﬂuctuations, and 1991; Khanna and Kalant 1992), suggesting that all
these compounds act directly or indirectly through theDBA mice are intermediary for these characteristics (Va-
latx and Buget 1974; Valatx 1984). The characteristic GABAergic system. Studying the differential sensitivity
of the LS and SS strains to various hypnotics or anesthe-free-running period is also 50 min longer in C57BL/6J
than in BALB/cByJ (Schwartz and Zimmerman 1990). tic agents has allowed investigation of whether the ge-
netic control of these compounds overlaps with that ofQualitative differences in EEG signals are also observed.
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ethanol (Marley et al. 1988; Erwin et al. 1990; Philips ning period t (Hall 1995; Takahashi 1995; Dunlap
1996; Sehgal et al. 1996). How these genes contributeand Dudek 1991; De Fiebre and Collins 1992; De Fie-
bre et al. 1992; Wehner et al. 1991, 1992). These stud- to the generation of 24-h rythmicity is still uncertain
(Hall 1996), but transcription-translation autoregula-ies demonstrate that there is some overlap for the
hypnotic effect of the less liposoluble anesthetic com- tory feedback loops are probably involved (Takahashi
1995). In Drosophila, for example, PER protein and perpounds (e.g., urethane and triﬂuorethanol) with etha-
nol. In contrast, liposoluble anesthetics, such as barbi- mRNA levels ﬂuctuate with a 3–4-h difference in phase,
and TIM is necessary for these ﬂuctuations to occur. Itturates, seem to produce similar effects in SS and LS
strains (De Fiebre et al. 1992), suggesting independent thus has been hypothesized that TIM interacts with PER
to enter into the nucleus and directly or indirectly regu-genetic control (Stino 1992). A preferred interaction
between the effects of ethanol and cholinergic (Erwin et lates the transcription of the per locus, with a delay, to
produce the 24-h rhythmicity (Dunlap 1996; Hall 1996;al. 1988; Overstreet et al. 1990; De Fiebre and Collins
1992) and dopaminergic (Phillips et al. 1989) transmis- Sehgal et al. 1996).
sion has also been suggested.
Second, these mouse stains are particularly useful for Circadian Rythmicity in Mammals and the
Suprachiasmatic Nucleuspurely genetic studies. A detailed phenotypic compari-
son of the SS and LS strains, as well as other strains
In mammals, research in the area is facilitated by the
hypersensitive to ethanol, suggests that the various phar-
fact that most circadian rhythms are generated in a dis-
macological effects of ethanol (sedation, hypothermy,
crete region of the hypothalamus, the suprachiasmatic
and toxicity) are controlled by different genes (Phillips
nuclei (‘‘SCN’’; for review, see Klein et al. 1991). Lesions
et al. 1989; Erwin et al. 1990; Phillips and Dudek 1991).
of these nuclei suppress all behavioral rhythms in ab-
Traditional segregation studies and phenotypic analysis
sence of time cues, whereas transplantation of fetal hy-
of SS1LS hybrids suggest that at least seven or eight
pothalamic tissue into lesioned animals restores circa-
genes are involved in the hypnotic effects of ethanol
dian ﬂuctuations. Mouse strains and mutant hamsters
(Dudek and Abbott 1984; DeFries et al. 1989). Quanti-
with abnormal free-running periods (t either too long
tative-trait locus (QTL) analysis has already been per-
or too short) have been identiﬁed (Klein et al. 1991;
formed in recombinant inbred strains, and multiple
Vitaterna et al. 1994). Transplanting mutant SCN tissue
QTLs have been identiﬁed (Crabbe et al. 1994; Markel
into the third ventricle of a normal animal whose supra-
et al. 1996).
chiasmatic nuclei had a former lesion induces an abnor-
The utility of these model strains for studying the
mal rhythmicity in the transplanted animal (Klein et al.
genetic control of sleep remains uncertain. Indeed, as of
1991). The neuronal, metabolic, and neurochemical ac-
today, LS and SS animals have not been studied for
tivity of SCN tissue also varies with a circadian periodic-
sleep and circadian rhythms, whether by use of either
ity in vitro (Klein et al. 1991). The mechanism by which
polygraphic recordings or wheel-running activity. More-
the SCN generates rhythmicity is still debated. The
over, the effect of benzodiazepines and alcohol on sleep
transplant probably generates rhythmicity independent
seems to be indirect and very dependent on previously
of any synaptic connection with the host tissue. Rhyth-
accumulated sleep debt (Roehrs et al. 1989; Zwyghu-
micity within the nuclei also seems independent of the
izen-Doorenbos et al. 1990; Edgar et al. 1991; Mignot
existence of synaptic connections, as individual neurons
et al. 1992). A better analysis of the sleep and circadian
and glial cells can generate circadian ﬂuctuations inde-
physiology of these model animals during baseline con-
pendently. These results appear to be parallel to what
ditions and after deprivation will be needed.
has been found in avian pineal glands or retina and in the
marine mollusk bulla (Takahashi 1995). On the basis of
Circadian Control in Drosophila, Neurospora, and the knowledge gathered from lower organisms, it is
Other Nonmamalian Organisms likely that transcription-translation mechanisms within
individual cells are a core phenomenon initiating overall
Circadian rhythmicity is an almost universal property
behavioral circadian rhythmicity across the animal king-
observed in most organisms, including some unicellular
dom. Synaptic organization in the SCN nucleus may
organisms (Takahashi 1995). A variety of mutations
thus coordinate and relay, rather than generate, rhyth-
have been reported to alter circadian rhythmicity inDro-
micity.
sophila, Neurospora, and Arabidosis (Dunlap 1993;
Millar et al. 1995). Research in this ﬁeld has already led
Clock, Gene Regulation, and Circadian Rythmicity in
to the isolation of two genes (‘‘period,’’ or per, and
Mammals
‘‘timeless,’’ or tim) in Drosophila and of one gene (‘‘fre-
quency,’’ or frq) in Neurospora, whose mutations can It generally is assumed that the genetic control of cir-
cadian rhythmicity is polygenic in mammals, as it is insuppress, decrease, or increase the circadian free-run-
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lower organisms, and several mutations with a strong bility of this approach is limited by the relatively large
number of animals (200–1,000) that need to be screenedeffect on free-running period have been reported (Ralph
and Menaker 1988; Vitaterna et al. 1994; Nolan et al. to ﬁnd a mutation of interest (Takahashi 1995). Another
strategy is to use QTL analysis and inbred mouse strains.1995; Takahashi 1995). One of these phenotypes is the
product of a spontaneous semidominant mutation, Tau This usually involves ﬁrst studying recombinant inbred
strains to identify possible genetic effects and pheno-(Ralph and Menaker 1988), in the golden hamster,
which induces a shorter free-running period and no types of interest and then verifying the QTLs by breeding
experiments, genetic typing, and building of congenicother apparent abnormalities. The two others, Clock
and Wheel, are dominant mutations in mice that are lines. These protocols have been used successfully for
numerous other multifactorial traits, from autoimmuneproduced through N-ethyl-N-nitrosurea germ-line mu-
tagenesis. Wheel is a complex neurological mutation diabetes in the nonobese diabetic (nod) mouse (Todd et
al. 1991) to drug response for addiction researchthat associates a complex array of abnormal behaviors
such as circling, hyperactivity, and abnormal circadian (Crabbe et al. 1994; Dudek and Tritto 1995). Candidate
QTLs for circadian rhythmicity in mice recently haverhythmicity and that has been mapped to mouse chro-
mosome 4 (Nolan et al. 1995). Clock is a pure circadian been reported in studies using available recombinant
inbred strains (Hofstetter et al. 1995; Maeda et al.mutation, associated with long free-running period, that
has been mapped to the midportion of mouse chromo- 1996). One important limitation of the QTL approach
is that genetic effects may be weak or very dependentsome 5, in a region of conserved synteny with human
chromosome 4. on genetic background. This makes the next step, gene
isolation, extremely difﬁcult, if not impossible, in manyThe positional cloning of Clock has recently been
sucessfully completed (Antoch et al. 1997; King et al. cases. An advantage of the QTL technique is that it may
lead to the isolation of naturally polymorphic factors1997). Interestingly, CLOCK is a member of the
bHLH-PAS protein family and shares sequence similar- that are involved in phenotypic variations; it is thus a
technique complementary to mutagenesis.ity with PER in the PAS domain that is known to be a
protein-dimerization interface. In contrast to PER in Another approach consists of direct examination of
‘‘candidate’’ genes in phenotypically distinct animalDrosophila, however, CLOCK also has a DNA binding
motif (bHLH), suggesting an ability to regulate gene strains. Korpi et al. (1993), for example, recently dem-
onstrated that a strain of rats particularly more resistanttranscription. Protein-protein interactions and regula-
tion of transcription are thus likely to be involved to benzodiazepines and alcohol carried a speciﬁc muta-
tion of the alpha-6 subunit of the GABA-A receptor.in generating circadian rythmicity across the animal
kingdom. This result agrees with the idea that sensitivity to alcohol
and to benzodiazepines proceeds from a common
GABAergic mechanism. Nevertheless, other genes andCloning Sleep and Circadian Genes in Mammals by
factors also seem to be involved, because mutations atUse of Rodent Models
this locus are not found in other strains of rodents sensi-
tive to sedatives or to alcohol (Korpi et al. 1993). TheEven for a relatively simple, anatomically localized
function such as the regulation of circadian rhythmicity candidate-gene approach will become more feasible as
more and more genes are isolated and sequenced and isin the suprachiasmatic nucleus, multiple genes are in-
volved. The situation is thus likely to be even more com- likely to be most powerful in humans. In this species,
gene isolation and sequencing is moving forward at aplex for normal and abnormal sleep regulation. Muta-
tions and variations in some of these genes will cause faster pace than in mice, and human disorders offer a
wide-open ﬁeld of investigation.pathological phenotypes in animals and humans,
whereas others may contribute to interindividual differ- Another research strategy that looks promising uses
genetically manipulated animal strains (transgenic orences or variations in sleep patterns within the same
species. ‘‘knockout’’) (Roemer et al. 1991; Travis 1992). If the
animal is viable, the analysis of the obtained phenotypeIn the search for these genes, mouse models are likely
to be one of the best tools for discovering sleep-related provides information on the normal function of the
modiﬁed gene. A recent example of this research stategygenes (Takahashi et al. 1994). Not only are rodents easy
to breed and study, but high-density marker maps, such was provided by the study of the prion knockout mouse
(Tobler et al. 1996). In this study, mice with a nullas the Whitehead Institute/MIT map, are now available.
One possible approach, already exempliﬁed for circa- mutation in the prion protein gene (PrP0/0), a gene associ-
ated with fatal familial insomnia and Creutzfeldt-Jakobdian rhythmicity, is to use mutagenesis to produce mu-
tants with sleep or circadian abnormalities and to isolate disease, were reported to display alterations in both cir-
cadian activity and sleep patterns (Tobler et al. 1996),the mutant genes through positional cloning. This is
clearly one of the most promising avenues, but the feasi- thus suggesting a role for the prion protein in sleep regu-
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lation. New mouse strains manipulated for one or multi- falling asleep. Sleep paralysis and cataplexy are both
pathological manifestations of REM-sleep atonia, butple candidate genes (neuroreceptors and enzymes and
candidate disease genes) are being developed at an in- only cataplexy is speciﬁc for the narcolepsy syndrome.
Hypnagogic hallucinations are dreamlike experiencescreasing pace. Ultimately, sleep and circadian rhythms
will also be studied in these mutants, and conclusions occurring at sleep onset or during sleep attacks.
Narcolepsy with cataplexy affects 0.02%–0.06% ofwill be drawn regarding the involvement of a given sys-
tem in the control of sleep. the general population in the United States and western
European countries (Solomon 1945; Dement et al. 1973;The study of genetically altered strains will soon lead
to the identiﬁcation of numerous genetic factors in- Aldrich 1992;Mignot, in press). It may be more frequent
(0.16%–0.18%) in Japan (Honda 1979; Mignot, involved in the physiological control of sleep in rodents.
The potential clinical implications of these research ave- press) and rarer in Israel (Lavie and Peled 1987). Since
its description in 1880 by Ge´lineau (1880), familial casesnues are still difﬁcult to measure. Only a fraction of the
genes identiﬁed in rodents will play a role in human have been reported by numerous authors (Daly and Yoss
1959; Nevsimalova-Bruhova 1973; Kessler et al. 1979;disease. The rodent models will, however, remain attrac-
tive for the design of better-controlled behavioral and Guilleminault et al. 1989; Singh et al. 1990; Billiard et
al. 1994), thus suggesting a genetic basis for narcolepsy.genetic studies.
This pathology thus offers a unique opportunity to dis-
cover genes involved in the control of sleep.Genetic Aspects of Pathological Human Sleep
More recent studies, however, suggest that narcolepsy
Numerous sleep pathologies, such as narcolepsy, fatal is not a simple genetic disorder (for review, see Mignot,
familial insomnia, sleep paralysis, hypnagogic hallucina- in press). The development of human narcolepsy in-
tions, sleep apnea, and restless-leg syndrome, are well volves environmental factors on a speciﬁc genetic back-
known for recurring with a high frequency in certain ground, and only 25%–31% of MZ twins reported in
families (Bornstein 1961; Roth et al. 1968; Kales et al. the literature are concordant for narcolepsy (Mignot, in
1980;Montplaisir et al. 1985; Lugaresi et al. 1986; Guil- press). One of the predisposing genetic factors is located
leminault et al. 1989; El Bayadi et al. 1990; Heath et in the major histocompatibility complex (MHC) DQ
al. 1990). All these results conﬁrm the existence of a region. Ninety to 100% of narcoleptic patients with
group of genes whose function is more speciﬁcally re- deﬁnite cataplexy share a speciﬁc human leukocyte anti-
lated to sleep. Genome screening is therefore another gen (HLA) class II allele, HLA DQB1*0602 (most often
possible research strategy for identiﬁcation of pathologi- in combination with HLA DR2), versus 12%–38% of
cal factors in sleep disorders. the general population in various ethnic groups (Honda
1983; Honda and Matsuki 1990; Matsuki et al. 1992;
Molecular Genetics and Narcolepsy-Cataplexy Rogers et al. 1997; Mignot et al., in press). The ﬁnding
of an HLA association in narcolepsy, together with theNarcolepsy is a disorder characterized by excessive
daytime sleepiness and abnormal REM sleep. Disease fact that HLA DQB1*0602 is likely to be the actual
HLA narcolepsy-susceptibility gene (Mignot et al. 1997;onset usually occurs at 15–25 years of age and only
exceptionally before puberty. Daytime somnolence is Mignot, in press), suggests that narcolepsy might be an
autoimmune disorder. However, to date, all attempts tousually the most disabling symptom; it frequently re-
quires life-long treatment with amphetamine-like stimu- demonstrate an immunopathology in narcolepsy have
failed, and the mode of action of HLA DQB1*0602 islants. Sleepiness can be objectively demonstrated in a
sleep laboratory using the Multiple Sleep Latency Test still uncertain (Matsuki et al. 1988; Rubin et al. 1988;
Fredrikson et al. 1990; Carlander et al. 1993; Mignot(MSLT). In this simple test, latencies to falling asleep
are measured during four or ﬁve short naps taken at 2- et al. 1995; Tafti et al. 1996).
Twelve to 38% of the general population carry HLAh intervals during the daytime, and the presence or ab-
sence of a REM-sleep transition is recorded. In narco- DQB1*0602, and only a small fraction have narcolepsy;
DQB1*0602 is thus a weakly penetrant genetic factorlepsy, sleep latencies are decreased (mean õ8 min), and
multiple (i.e., more than two) REM-sleep transitions are (lHLA Å 2), even if genetic association with the disorder
is high. Other genetic factors, possibly more penetrantobserved. Cataplexy, sleep paralysis, and hypnagogic
hallucinations are frequently associated symptoms. In than HLA, are likely to be involved. One to 2% of
the ﬁrst-degree relatives of a patient with narcolepsy-cataplexy, brief episodes of muscle weakness resulting
in knees buckling, jaw sagging, head dropping, or, less cataplexy are affected by the disorder, versus 0.02%–
0.06% in the general population in various ethnicfrequently, full-body paralysis are observed when the
patient is laughing or elated. In sleep paralysis, the pa- groups, yielding a lsiblings of 20–40-fold increased risk
(Guilleminault et al. 1989; Billiard et al. 1994; Mignot,tient ﬁnds him- or herself unable to move for a few
seconds to several minutes when waking up or when in press). Familial aggregation cannot be explained by
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the sharing of HLA haplotypes alone (Mignot, in press), symptoms, intellectual deterioration, and death (Lugar-
esi et al. 1986; Julien et al. 1990; Goldfarb et al. 1992;and some families are non-HLA DQB1*0602 positive
(Guilleminault et al. 1989), thus suggesting the impor- Manetto et al. 1992). Insomnia is an early sign, and
sleep disruption is associated with a disappearance oftance of non–HLA susceptibility genes that could be
positionally cloned by use of genome-screening ap- stage II light sleep and SWS, whereas brief episodes of
REM sleep are usually maintained. Neuropathologicalproaches in human multiplex families or in isolated pop-
ulations. lesions are mostly limited to a spongiform degeneration
of the anterior ventral and mediodorsal thalamic nucleiStudies using a canine model of narcolepsy also illus-
trate the importance of non-MHC genes. In this model, and of the inferior olive (Manetto et al. 1992). This
pathology is typically associated with a mutation of thenarcolepsy-cataplexy is transmitted as a single autoso-
mal recessive trait with full penetrance, canarc-1 (Baker codon 178 in the prion protein gene, but one recent
report detected a codon 200 mutation (Chapman et al.and Dement 1985; Mignot et al. 1992, 1993). This high-
penetrance narcolepsy gene is unlinked to MHC class II 1996). These same mutations are also found in Creutz-
feldt-Jakob disease, but a polymorphism at codon 129but cosegregates with a DNA segment with high homol-
ogy to the human immunoglobulin m-switch sequence seems to determine the phenotypic expression of fatal
familial insomnia rather than Creutzfeldt-Jakob demen-(Mignot et al. 1991). This linkage marker is located very
close to the narcolepsy gene (current LOD score 15.3 at tia (Goldfarb et al. 1992; Chapman et al. 1996).
The prion protein is encoded by a gene located on0% recombination), and gene isolation is ongoing both
in canines and in the corresponding human region of human chromosome 20. The normal function of the
protein is unknown, but the gene is expressed in neu-conserved synteny.
rons. Mice homozygous for mutations disrupting the
Genetics and Dissociated-REM-Sleep Events prion protein gene are behaviorally normal but may dis-
play sleep abnormalities (Tobler et al. 1996). Prions areSleep paralysis and hypnagogic hallucinations, two
symptoms of dissociated REM sleep, occur frequently involved in a group of human and animal disorders with
more or less anatomically conﬁned spongious degenera-in the general population, independently of narcolepsy
(Dalhitz et al. 1992; Oyahon et al. 1996). Sleep paralysis tion and neuronal atrophy (spongiform encephalopa-
thies). A proteinase-resistant form of the prion proteinis highly familial, and autosomal dominant transmission
has been observed in some cases (Goode 1962; Roth et is probably involved in the pathology (Prusiner et al.
1991). These diseases can appear either in a familialal. 1968; Nevsimalova-Bruhova 1973; Bell et al. 1986).
For this symptom, twin studies suggest a much higher context or in an infectious context, the prion protein (or
an agent that cannot be distinguished from the proteicconcordance in MZ twins versus DZ twins (Hori and
Hirose 1995), which may be more frequent in the black element) acting as the transmitting agent. The mecha-
nism by which certain isoforms of the protein are infec-population (Bell et al. 1986). There is no association
with HLA DQB1*0602 (Dalhitz et al. 1992). tious remains a widely discussed topic (Weissman 1991;
Mestel 1996).In REM-sleep behavior disorder (RBD), motor behav-
iors arise during REM sleep and disturb sleep continuity How a simple additional polymorphism on codon 129
alters the symptomatology from Creutzfeldt-Jakob dis-(Mahowald and Schenck 1994). RBD is frequently asso-
ciated with other pathologies, such as narcolepsy, but ease to fatal familial insomnia is not understood, but
molecular studies are underway to evaluate the effectmay occur in isolation (Mahowald and Schenck 1994).
The familiality of isolated RBD is not established, but that these mutations have on the metabolism of the pro-
tein (Petersen et al. 1996). The differences in symptom-the disorder may be weakly associated with HLA DQ1
(Schenck et al. 1996) atology are probably due to a differential anatomic lo-
calization of the lesions. In fatal familial insomnia,Cataplexy without sleepiness is exceptional (Aldrich
1992), but some rare familial cases with or without asso- degeneration primarily localizes in the anterior ventral
and mediodorsal thalamic nuclei, whereas lesions areciated sleep paralysis have been described (Gelardi and
Brown 1967; Vela Bueno et al. 1978; Hartse et al. 1988). much more diffuse in Creutzfeldt-Jakob disease (Weiss-
man 1991; Lugaresi 1992). The well-established role ofIn many of these cases, however, clinical presentation
seems to differ quite signiﬁcantly from narcolepsy-cata- the thalamus (albeit mostly of the intralaminar thala-
mus) and of its cortical projections in the generation ofplexy and cataplexy presented in the ﬁrst months of life
(Vela Bueno et al. 1978; Hartse et al. 1988). HLA typing the cortical synchronization of SWS and sleep spindles
(Ste´riade 1992) suggests that thalamic lesions may causehas not been done for these families.
the insomnia in this disorder (Lugaresi 1992). As of
Molecular Genetics and Fatal Familial Insomnia today, however, no study has convincingly demon-
strated that the destruction of these nuclei can produceFatal familial insomnia is a rare neurological condi-
tion characterized by severe insomnia, neurovegetative a fatal insomnia in animal models. Bilateral lesions of
/ 9a2a$$ju45 05-21-97 19:24:03 ajhga UC-AJHG
1295Mignot: Behavioral Genetics ’97
these nuclei produce a persistent insomnia that is not compared with 3.5% and 0.5%, respectively, for ﬁrst-
and second-degree relatives of control subjects and sug-fatal (Marini et al. 1988). Therefore, other, more dis-
crete anatomical lesions or a distinct pathophysiological gested a lsiblings of Ç5 (Labuda 1997). Linkage studies
using either microsatellite markers or candidate genesmechanism could also play a role. Transgenic mice car-
rying the human prion allele speciﬁc for fatal familial in multiplex families are ongoing in order to identify the
gene(s) involved (Johnson et al. 1992; J. Montplaisir,insomnia have now been generated and are under study
to answer these questions. personal communication). Possible candidate genes are
enzymes and receptors of the dopaminergic and enkeph-The implication of the thalamus in the pathophysiol-
ogy of fatal familial insomnia suggests that this brain alinergic metabolisms, two neurotransmitters involved
in the pharmacological treatment of the syndrome. Asstructure may be involved in the genesis of other, more
frequent insomnias. Insomnia is a very frequent symp- of today, however, no result suggestive of linkage has
been published.tom that affects §10% of the general population (Na-
tional Institute of Mental Health 1984; Angst et al.
Genetic Aspects of Sleepwalking, Sleeptalking, and1989). Many insomnias appear to be constitutional
Night Terrors(Hauri 1989), and genetic factors inﬂuencing the thala-
mus and homeostatic abnormalities in the regulation of These parasomnias generally occur during SWS
(stage III and stage IV) (Keefauver and Guilleminaultsleep may be involved in some cases. Other genetic fac-
tors, such as those regulating circadian rhythmicity at 1994). They are usually grouped together and consid-
ered to share a common or related pathophysiologicalthe level of suprachiasmatic nuclei, could be involved in
other cases. mechanism (Broughton 1968), although this notion is
sometimes disputed (Keefauver and Guilleminault
Genetic Aspects of Restless-Leg Syndrome and 1994). The prevalence of these symptoms is several
Periodic Limb Movements percent among children and only scarcely requires a
medical consultation. Symptoms generally disappear inRestless-leg syndrome (RLS) is a frequent (2%–5%
of general population) (Ekbom et al. 1960; Strang 1967; adulthood (Abe and Shimakawa 1966; Keefauver and
Guilleminault 1994).Montplaisir et al. 1994) syndrome that worsens with
age and affects both sexes. RLS is almost always associ- The familial nature of these symptoms has been rec-
ognized bymost authors (Debray andHuon 1973;Ha¨ls-ated with periodic leg movements (PLM) during sleep.
RLS is best deﬁned as unconfortable or painful sensa- trom et al. 1972; Kales et al. 1980; Abe et al. 1984),
but the exact mode of transmission is uncertain. Twintions in the legs, which force the patient to get up several
times each night (Montplaisir et al. 1994; Walters and studies have shown a high degree of concordance for
sleepwalking and night terror (50% in MZ twins andInternational RLS Study Group 1995). PLM are brief
and repetitive muscular jerks of the lower limbs, oc- 10%–15% in DZ twins) (Bakwin 1970; Hori and Hir-
ose 1995; Hublin et al. 1997). The genetic predisposi-curring mostly during stage II sleep (Montplaisir et al.
1994). When these movements increase in strength and tion to sleepwalking, sleeptalking, and, to a lesser de-
gree, night terrors and enuresis may overlap. Indeed,frequency, sleep is altered. RLS is highly familial and as
many as one-third of the reported cases may transmit the frequency of sleep terrors and enuresis might be
more frequent in families with somnambulism (Debraythe condition as an autosomal dominant trait (Bornstein
1961; Ambrosetto et al. 1965; Montagna et al. 1983; and Huon 1973; Kales et al. 1980; Abe et al. 1984).
This suggests a related pathophysiological mechanismJacobsen et al. 1986; Walters et al. 1990, 1994; Trenk-
walder et al. 1996) with possible genetic anticipation and similar genetic control. As of today, however, there
has not been any molecular study initiated on these(Trenkwalder et al. 1996). Unfortunately, no twin study
is available, and both the prevalence and the proportion pathologies.
of familial cases seem to vary widely according to the
Obstructive Sleep–Apnea Syndrome and Relatedgeographical origin of the population studied. These dif-
Breathing Abnormalities during Sleepferences may reﬂect either founder effects, such as in
Quebec, where one ﬁnds a high proportion of familial Obstructive-sleep-apnea syndrome (OSAS) is a com-
plex syndrome in which the upper airway collapses re-cases (Montplaisir et al. 1994) and a higher prevalence
(Lavigne andMontplaisir 1994), or the inﬂuence of local petitively during sleep, thus blocking breathing (Gastaud
et al. 1965). Snoring is one of the cardinal symptoms.environmental factors.
Population-based risk estimations in ﬁrst- and second- Repeated apneas prevent the patient from sleeping
soundly, and the patient is frequently excessively sleepydegree relatives are not yet available for this interesting
pathology. In a recent study published only as an ab- the following day. Four to 5% of the general population
suffer from OSAS (Lugaresi et al. 1986; Young et al.tract, risks to ﬁrst- and second-degree relatives were
19.9% and 4.1%, respectively (Labuda 1997). This 1993), which, in the longer term, leads to high blood
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pressure and increased risk for cardiovascular accidents ported to experience sleep disturbances and low melato-
(Guilleminault et al. 1975; Koskenvuo et al. 1985; Hall nin levels (O’Hare et al. 1986; Staley-Gane et al. 1996),
and Bradley 1995). Recent studies suggest increased vul- whereas subjects with either Norrie disease (genetic al-
nerability in African Americans (Redline et al. 1997). terations in a region encompassing the monoamine oxi-
Twin studies are lacking in OSAS, but, for habitual dase genes at Xp11.3) or Nieman-Pick type C (18q11-
snoring, two recent studies have shown higher concor- q12) may experience cataplexy and sleep disturbances
dance in MZ twins versus DZ twins (Ferini-Strambi et (Challamel et al. 1994; Vossler et al. 1996). An interest-
al. 1995; Hori and Hirose 1995). Multiplex families of ing family with autosomal dominant cerebral ataxia,
patients suffering from OSAS have also been reported deafness, normal karyotype, and clinically deﬁned nar-
in the literature (Strohl et al. 1978; Adickes et al. 1986; colepsy with cataplexy also has been described and
Oren et al. 1987; Manon-Espaillat et al. 1988; Wittig shown to be non–HLA DR2 associated (Melberg et al.
et al. 1988; El Bayadi et al. 1990; Mathur and Douglas 1995). OSAS are also frequently observed as a result of
1995; Pillar and Lavie 1995; Redline et al. 1995), and anatomic malformations, adenotonsilar enlargement, or
one study found a substantial increase of HLA A2 and morbid obesity (e.g., see Goldberg et al. 1980; Kaplan
HLA B39 in Japanese patients with OSAS (Yoshizawa et al. 1991; Carskadon et al. 1993). In a few instances,
et al. 1993). Familial aggregation is generally explained however, polygraphic studies suggest that central factors
by the fact that most risk factors involved in the physio- are also involved in addition to or independently of ab-
pathology of sleep apnea are, in large part, genetically normal breathing during sleep. This may be the case for
determined. These include obesity, alcoholism, and fa- the Prader-Willi and Angelman syndromes (del[15q])
cial soft-tissue and bone anatomy, which all predispose (Kaplan et al. 1991; Summers et al. 1992; Vgontzas et al.
to upper-airway obstruction (for discussion, see El Bay- 1996) or the Smith Magenis syndrome (del[17][p11.2])
adi et al. 1990; Guilleminault et al. 1995; Mathur and (Greenberg et al. 1991; Fischer et al. 1993).
Douglas 1995; Redline et al. 1995; Kronholm et al. In spite of their relatively high population frequency,
1996). In some cases, the genetic factor primarily in- the effects of sex-chromosomal aneuploidies on sleep
volves abnormal ventilatory control by the CNS (Ad- have been only marginally studied, but XXY subjects
ickes et al. 1986; El Bayadi et al. 1990). A possible may display increased 24-h sleep time (Higurashi et al.
genetic overlap between OSAS and sudden infant death 1986). The general topic of abnormal hormonal control
(Adickes et al. 1986; Oren et al. 1987; Tishler et al. and sleep in these patients would be worth investigating
1996) and the high degree of concordance in chemore- more thoroughly, because puberty is associated with es-
ceptor responses observed in MZ twins (Kawakami et tablished changes in sleep needs (Carskadon 1990).
al. 1982; Thomas et al. 1993) suggests the importance Moreover, narcolepsy often starts with adolescence, and
of genetic factors regulating the central control of venti- in two cases narcolepsy started at the unusual age of 6
lation in OSAS. years, in a Turner syndrome patient (XO) (George and
A multiplicity of genetic factors is likely to correspond Singh 1991), or in coincidence with a precocious puberty
to the multifactorial aspect of OSAS. A genetic-linkage (Chilshlom et al. 1985).
approach in OSAS would thus be facilitated by a careful
phenotypic analysis—for example, study of sleepy or
Other Sleep Pathologiesnonsleepy subjects, nonobsese versus obese OSAS pa-
Insomnia, obstructive sleep apnea, narcolepsy, peri-tients (Guilleminault et al. 1995), or subjects with se-
odic movements and RLS syndrome, parasomnias, andlected mophological features (Kushida et al. 1996).
circadian disorders are the most frequent sleep patholo-
Chromosomal and Genetic Abnormalities and Sleep gies. There are few or no studies on other forms of
Disturbances hypersomnias or parasomnias. One twin study suggests
increased frequency of bruxism (teeth grinding duringThe coincidental association of speciﬁc chromosomal
sleep) in MZ twins versus DZ twins (Hori and Hirosebreakpoints with speciﬁc pathologies can be very useful
1995), and bruxism has been reported in a multiplexto help localize the susceptibility gene(s). In practice,
context (Hartman 1989). Familial forms of essentialhowever, karyotypes are rarely requested when a sleep
hypersomnia (Nevsimalova-Bruhova 1973), of hyper-disorder is the primary abnormality, and very few sleep
somnias associated with either dystrophia myotonicastudies have been performed in patients with chromo-
(Manni et al. 1991) or sleep-responsive extrapyramidalsomal or genetic abnormalities. These disorders fre-
dystonias (Byrne et al. 1991; Ishikawa and Miyatakequently produce behavioral and medical problems that
1995), and of jactatio capitis nocturna (Thorpy andhave secondary effects on sleep, particularly disturbed
Glovinsky 1989) have also been reported. A possiblenocturnal sleep, so it may difﬁcult to identify a disease-
association of idiopathic hypersomnias with HLA Cw2speciﬁc sleep phenotype (Carskadon et al. 1993). In spite
of these limitations, fragile X subjects have been re- and of hypersomnia in dystrophia myotonica with DR6
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tiﬁcation of the mouse circadian Clock gene by transgenichas also been found (Poirier et al. 1986; Manni et al.
BAC rescue. Cell 89:655–6671991) but would need independent conﬁrmation.
Baker TL, Dement WC (1985) Canine narcolepsy-cataplexy
syndrome: evidence for an inherited monoaminergic-cholin-Perspectives in Human Genetic Research in Sleep
ergic imbalance. In: McGinty DJ, Drucker-Colin R, Mor-Disorders risson A (eds) Brain mechanisms of sleep. Raven Press, New
York, pp 199–233The complexity of sleep as a physiological phenome-
Bakwin H (1970) Sleepwalking in twins. Lancet 2:466–467non is matched by a vast number of pathologies. Most
Bell GC, Dixie-Bell DD, Thompson B (1986) Further studiesof these pathologies are multifactorial and, to a large
on the prevalence of isolated sleep paralysis in black sub-extent, genetically determined. The recent progress of
jects. J Natl Med Assoc 78(7): 649–659
molecular genetics has enabled researchers to undertake Benca RM, Bergman BM, Leung C, Nummy D, Rechtschaffen
a purely genetic approach to understand the pathophysi- A (1991) Rat strain differences in response to dark pulse
ology of these disorders. This approach will most likely triggering of paradoxical sleep. Physiol Behav 49:83–87
ﬁrst lead to the identiﬁcation of genes involved in etio- Billiard M, Pasquie-Magentto, Heckman M, Carlander B, Bes-
logically homogeneous sleep disorders such as narco- set A, Zachariev Z, Eliaou JF, et al (1994) Family studies
in narcolepsy. Sleep Suppl 17:S54–S59lepsy. Genome-screening studies in more frequent and
Bornstein B (1961) Restless leg syndrome. Psychiatr Neurolcomplex sleep disorders, such as OSAS or RLS, will
141:165–201require the inclusion of a large number of multiplex
Broughton RJ (1968) Sleep disorders: disorders of arousal?families but are now feasible. These disorders may also
Science 159:1070–1078beneﬁt from studies in isolated populations or even from
Byrne E, White O, Cook M (1991) Familial dystonic choreo-association studies using very large numbers of single-
athetosis with myyokymia: a sleep responsive disorder. J
case families; this last design has the beneﬁt of being Neurol Neurosurg Psychiatry 54:1090–1092
easily used for candidate-gene studies. Those are likely Carlander B, Eliaou JF, Billiard M (1993) Autoimmune hy-
to become a more viable research strategy as more and pothesis in narcolepsy. Neurophysiol Clin 23:15–22
more genes are cloned and positioned on the human Carskadon MA (1990) Patterns of sleep and sleepiness in ado-
map and as possible candidate genes are identiﬁed in lescents. Pediatrician 17(1): 5–12
Carskadon MA, Pueschel SM, Millman RP (1993) Sleep-disor-mouse models.
dered breathing and behavior in three risk groups: prelimi-
nary ﬁndings from parental reports. Childs Nerv Syst 9(8):
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